3 stocks to double your portfolio in 10 years

A 100% return isn't as hard as you'd think.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's important that investors remain grounded and realistic in their expectations of achievable returns. Generally the longer someone has been investing, the more they come to realise what is and isn't achievable. In contrast, investors new to the stockmarket are more likely to 'swing for the fences' with expectations that they will earn enormous returns on every trade.

As I highlighted recently in this article, investors need only make a mid-single digit return, compounded for many years to achieve a comfortable retirement……

In fact to double your money within ten years only requires a 7.2% return compounded annually!

Given the S&P/ASX 300 Accumulation Index has achieved an annualised return of 8.9% over the past decade, an investor could actually have done worse than the market average and still doubled their money.

With the above returns in mind, here are three stocks which have the potential to help investors achieve a return of at least 7.2% per annum (pa) over the coming ten years.

Vertically integrated gas producer, electricity generator and retailer Origin Energy Limited (ASX: ORG) has provided shareholders with a Total Shareholder Return (TSR) of 12.9% pa for the past decade. With an unfranked yield of 3.5% and plenty of earnings growth set to occur as APLNG begins to flow. There appears a decent chance that a TSR of above 7.2% can be achieved over the next decade.

Ansell Limited (ASX: ANN) is a global manufacturer of health and safety protection products. For the past decade the firm has achieved a TSR of 11.5% pa. With an unfranked yield of 1.8%, investors will be looking for most of their returns to be achieved through share price appreciation. With a solid earnings growth outlook and the company trading on a reasonable multiple this again looks achievable.

Leading international medical diagnostics company Sonic Healthcare Limited (ASX: SHL) has achieved a TSR of 11.4%pa in the last 10 years. With the stock currently trading on a partially franked yield of 3.8%, it only needs to achieve share price appreciation of approximately 3.4% pa. This growth rate would appear quite possible given the multitude of opportunities to expand its business.

Motley Fool contributor Tim McArthur owns shares in Origin Energy Ltd.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »